Neurable, a neurotechnology company, secures $13million in funding. Backers included Ultratech Capital Partners, TRAC, Pace Ventures, and Metaplanet.
The money will be utilised by the company to develop its platform, which will provide access to non-invasive BCI technology for businesses and original equipment manufacturers (OEMs), as well as broad consumer audience availability.
In order to improve human performance, this entails broadening the company’s range of products, reference designs, algorithms, and enabled systems to include earphones, helmets, and other head-worn devices.
Neurable is a neurotechnology firm led by Dr. Ramses Alcaide, the CEO. The business specialises in developing AI-powered tools for brain-computer interface and brain signal translation.
Read also – CA-based Docusign Agrees to Acquire Lexion
Its platform enables high-performance brain-computer interface in common products. It is driven by patented signal processing, developed via research across laboratories and universities, and enhanced by a scientific and professional product team.
The business, which has generated more than $30 million since its foundation, is collaborating with its network of licencing partners to bring neurotechnology to life, one of the ways being through the impending release of the Neurable AI-powered MW75 Neuro headphones.
About Neurable
The goal of Neurable is to establish a world free from constraints for human habitation. People may now operate software and gadgets with just their brain activity thanks to their ground-breaking brain-computer interface.
